These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17721547)

  • 1. A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist.
    Wilkinson IR; Ferrandis E; Artymiuk PJ; Teillot M; Soulard C; Touvay C; Pradhananga SL; Justice S; Wu Z; Leung KC; Strasburger CJ; Sayers JR; Ross RJ
    Nat Med; 2007 Sep; 13(9):1108-13. PubMed ID: 17721547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition events involved in the activation of the growth hormone receptor by growth hormone.
    Behncken SN; Waters MJ
    J Mol Recognit; 1999; 12(6):355-62. PubMed ID: 10611645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity, toxicology, pharmacokinetics and pharmacodynamics of growth hormone ligand-receptor fusions.
    Ferrandis E; Pradhananga SL; Touvay C; Kinoshita C; Wilkinson IR; Stafford K; Wu Z; Strasburger CJ; Sayers JR; Artymiuk PJ; Ross RJ
    Clin Sci (Lond); 2010 Aug; 119(11):483-91. PubMed ID: 20597861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystals of human growth hormone-receptor complexes. Extracellular domains of the growth hormone and prolactin receptors and a hormone mutant designed to prevent receptor dimerization.
    Ultsch M; de Vos AM
    J Mol Biol; 1993 Jun; 231(4):1133-6. PubMed ID: 8515471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfide bonds determine growth hormone receptor folding, dimerisation and ligand binding.
    van den Eijnden MJ; Lahaye LL; Strous GJ
    J Cell Sci; 2006 Aug; 119(Pt 15):3078-86. PubMed ID: 16820415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational detection of the binding-site hot spot at the remodeled human growth hormone-receptor interface.
    Verkhivker GM; Bouzida D; Gehlhaar DK; Rejto PA; Freer ST; Rose PW
    Proteins; 2003 Nov; 53(2):201-19. PubMed ID: 14517972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer.
    Brown RJ; Adams JJ; Pelekanos RA; Wan Y; McKinstry WJ; Palethorpe K; Seeber RM; Monks TA; Eidne KA; Parker MW; Waters MJ
    Nat Struct Mol Biol; 2005 Sep; 12(9):814-21. PubMed ID: 16116438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors.
    Kossiakoff AA
    Adv Protein Chem; 2004; 68():147-69. PubMed ID: 15500861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turning the growth hormone receptor on: evidence that hormone binding induces subunit rotation.
    Poger D; Mark AE
    Proteins; 2010 Apr; 78(5):1163-74. PubMed ID: 19927328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the growth hormone-receptor complex and mechanism of receptor signaling.
    Kossiakoff AA
    J Nucl Med; 1995 Jun; 36(6 Suppl):14S-16S. PubMed ID: 7769459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH), GH receptor, and signal transduction.
    Kopchick JJ; Andry JM
    Mol Genet Metab; 2000; 71(1-2):293-314. PubMed ID: 11001823
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel assays based on human growth hormone receptor as alternatives to the rat weight gain bioassay for recombinant human growth hormone.
    Roswall EC; Mukku VR; Chen AB; Hoff EH; Chu H; McKay PA; Olson KC; Battersby JE; Gehant RL; Meunier A; Garnick RL
    Biologicals; 1996 Mar; 24(1):25-39. PubMed ID: 8733599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of alpha-helical cytokine-receptor complexes: we've only scratched the surface.
    Walter MR
    Biotechniques; 2002 Oct; Suppl():46-8, 50-7. PubMed ID: 12395927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth hormone and prolactin receptors belong to a new receptor family. Biological and medical aspects].
    Skibeli V; Rokkones E; Gautvik KM
    Tidsskr Nor Laegeforen; 1993 Feb; 113(6):725-30. PubMed ID: 8465339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor.
    Walter MR; Windsor WT; Nagabhushan TL; Lundell DJ; Lunn CA; Zauodny PJ; Narula SK
    Nature; 1995 Jul; 376(6537):230-5. PubMed ID: 7617032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone receptor; mechanism of action.
    Brooks AJ; Wooh JW; Tunny KA; Waters MJ
    Int J Biochem Cell Biol; 2008; 40(10):1984-9. PubMed ID: 17888716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of action of growth hormone--receptor binding and postreceptor signal transduction].
    Matsuzaki F
    Nihon Rinsho; 1993 Oct; 51(10):2624-30. PubMed ID: 8254930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of extracellular domain dimerization in agonist-induced activation of natriuretic peptide receptor A.
    Parat M; McNicoll N; Wilkes B; Fournier A; De Léan A
    Mol Pharmacol; 2008 Feb; 73(2):431-40. PubMed ID: 17965196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors: simulations using a novel multipoint steered molecular dynamics approach.
    Martínez L; Polikarpov I; Skaf MS
    J Phys Chem B; 2008 Aug; 112(34):10741-51. PubMed ID: 18681473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-receptor interactions at the parathyroid hormone receptors: subtype binding selectivity is mediated via an interaction between residue 23 on the ligand and residue 41 on the receptor.
    Mann R; Wigglesworth MJ; Donnelly D
    Mol Pharmacol; 2008 Sep; 74(3):605-13. PubMed ID: 18539702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.